NCT01496053

Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD)

Anti-inflammatory Effect of a Mushroom Extract (AndoSan)in Patients With Inflammatory Bowel Disease. A Prospective Study

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Oslo University Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

Examine whether daily oral ingestion of a immunomodulatory mushroom extract (AndoSanTM) in patients with ulcerative colitis (UC) and Crohn's disease (CD), experience clinical, biochemical and genetical improvement in their disease. A prospective randomised study comparing the mushroom extract with placebo.

Conditions

• Ulcerative Colitis
• Crohn's Disease
• Inflammatory Bowel Disease

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	AndoSan	AndoSan 30 ml x 2 for 21 days
DIETARY_SUPPLEMENT	Sugar Extract	Sham comparator

Timeline

• Start date: 2011-12-01
• Primary completion: 2015-12-01
• Completion: 2016-01-01
• First posted: 2011-12-21
• Last updated: 2020-10-08

Locations

1 site across 1 country: Norway